- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03499535
Impact of Smoking Information on Concerns About Radon
17. april 2019 oppdatert av: Paul Windschitl
Despite a push for tailored messages, health communications are often aimed at, and viewed by, people with varying levels of risk.
This project examined-in the context of radon risk messages-whether information relevant to high-risk individuals can have an unintended influence on lower-risk individuals.
Specifically, the investigators assessed whether information about lung-cancer risk from smoking reduced concerns about lung-cancer risk from radon among nonsmokers.
The investigators hypothesized that non-smokers who read a message that included smoking-relevant information would express less concern about the effects of radon exposure and less interest in testing their home compared to those who read a version in which smoking-relevant information was excluded.
Two studies were conducted.
Although the investigators did not exclude smokers, the focus was on participants self-identifying as nonsmokers (including never smokers and former smokers).
Studieoversikt
Status
Fullført
Detaljert beskrivelse
Despite a push for tailored messages, health communications are often aimed at, and viewed by, people with varying levels of risk.
This project examined-in the context of radon risk messages-whether information relevant to high-risk individuals can have an unintended influence on lower-risk individuals.
Specifically, the investigators assessed whether information about lung-cancer risk from smoking reduced concerns about lung-cancer risk from radon among nonsmokers.
The investigators hypothesized that non-smokers who read a message that included smoking-relevant information would express less concern about the effects of radon exposure and less interest in testing their home compared to those who read a version in which smoking-relevant information was excluded.
Two studies were conducted.
Although the investigators did not exclude smokers, the focus was on participants self-identifying as nonsmokers (including never smokers and former smokers).
Participants in both studies were recruited through Amazon's Mechanical Turk (MTurk).
Participants viewed radon messages that varied in the information they communicated about smoking's effect on lung cancer.
In Study 1, smoking information was included or excluded from messages assembled from existing radon pamphlets.
In Study 2, versions of a new radon message either excluded smoking information, described smoking as a major cause of lung cancer, or also described smoking's synergistic effect with radon on lung cancer risk.
After viewing a radon health message, participants completed a variety of measures.
Primary measures assessed respondents' anticipated sense of concern and related reactions if they learned that they/their home had been exposed to elevated levels of radon.
Other key measures included questions about participants' interest and intention to test their home for radon.
Studietype
Intervensjonell
Registrering (Faktiske)
1390
Fase
- Ikke aktuelt
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Live within the US
- Have an Amazon Mechanical Turk account (website where online study was posted)
Exclusion Criteria:
- None
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Faktoriell oppgave
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Study 1: Radon&Smoking Synergistic/EPA
Participants viewed radon and smoking risk information taken from the EPA's pamphlet on the dangers of radon gas exposure.
|
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects.
This intervention represents the type of information most commonly presented in radon risk communications.
Health information modeled after the Environmental Protection Agency's (EPA) pamphlet on radon risk.
|
|
Aktiv komparator: Study 1: Radon&Smoking Synergistic/Idaho
Participants viewed radon and smoking risk information taken from Idaho's Department of Health and Human Welfare's pamphlet on the dangers of radon gas exposure.
|
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects.
This intervention represents the type of information most commonly presented in radon risk communications.
Health information modeled after the Idaho Department of Health and Human Welfare's pamphlet on radon risk.
|
|
Eksperimentell: Study 1: Radon Only / EPA
Participants viewed only radon risk information taken from the EPA's pamphlet on the dangers of radon gas exposure.
|
Health information modeled after the Environmental Protection Agency's (EPA) pamphlet on radon risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure.
No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
|
|
Eksperimentell: Study 1: Radon Only / Idaho
Participants viewed only radon risk information taken from Idaho's Department of Health and Human Welfare's pamphlet on the dangers of radon gas exposure.
|
Health information modeled after the Idaho Department of Health and Human Welfare's pamphlet on radon risk.
Participants viewed health information detailing the risks of developing lung cancer from radon exposure.
No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
|
|
Eksperimentell: Study 2: Radon Only
Participants viewed a radon-only message that focused only on the effect of radon on lung-cancer risk.
|
Participants viewed health information detailing the risks of developing lung cancer from radon exposure.
No information about the risks for developing lung cancer associated with smoking or its synergistic effect with radon exposure are included.
|
|
Annen: Study 2: Radon and Smoking Isolated
Participants viewed a radon-and-smoking-isolated message that covered the individual effects of radon and of smoking on lung cancer, but without mentioning their synergistic effect.
|
Participants viewed health information detailing the risks of developing lung cancer from radon exposure and smoking.
No information describing the synergistic effects of smoking and radon exposure on lung cancer risk are included.
|
|
Aktiv komparator: Study 2: Radon & Smoking Synergistic
Participants viewed a radon-and-smoking-synergistic message that covered the individual effects of radon and of smoking but that also included information about their synergistic effect.
|
Participants viewed health information detailing the risks of developing lung cancer from exposure to radon gas, smoking, and their synergistic effects.
This intervention represents the type of information most commonly presented in radon risk communications.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Conditional Concern Composite
Tidsramme: Immediately post-intervention (approx. 1 minute)
|
Composite formed from 4 conditional questions assessing concern, perceived impact on risk and comparative risk, and threat--if exposed to radon
|
Immediately post-intervention (approx. 1 minute)
|
|
Interest in Testing Composite
Tidsramme: Immediately post-intervention (approx. 2 minutes)
|
Composite formed from 2 questions assessing importance and intention to test home for radon
|
Immediately post-intervention (approx. 2 minutes)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Worry Elicited by Health Message
Tidsramme: Immediately post-intervention (approx. 2 minutes)
|
Single question assessing worry elicited by the health communication material
|
Immediately post-intervention (approx. 2 minutes)
|
|
Likelihood Judgments about Lung Cancer
Tidsramme: Immediately post-intervention (approx. 4 minutes)
|
Three items assessing perceived likelihood of developing lung cancer
|
Immediately post-intervention (approx. 4 minutes)
|
|
Elect to Leave Email for Raffle
Tidsramme: Immediately post-intervention (approx. 4 minutes)
|
Participants given option to leave email address in case they won one of the 20 radon kits being raffled (Study 2).
|
Immediately post-intervention (approx. 4 minutes)
|
|
Elect to Read More
Tidsramme: Immediately post-intervention (approx. 4 minutes)
|
Participants given option to be presented with more information at the end of the session about testing for radon (Study 2).
|
Immediately post-intervention (approx. 4 minutes)
|
|
Concern about Loved Ones If Exposed to Radon
Tidsramme: Immediately post-intervention (approx. 4 minutes)
|
Rated how concerned they would be about loved ones if they learned their home had high radon (Study 2)
|
Immediately post-intervention (approx. 4 minutes)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
7. august 2015
Primær fullføring (Faktiske)
22. april 2016
Studiet fullført (Faktiske)
22. april 2016
Datoer for studieregistrering
Først innsendt
30. mars 2018
Først innsendt som oppfylte QC-kriteriene
13. april 2018
Først lagt ut (Faktiske)
17. april 2018
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
19. april 2019
Siste oppdatering sendt inn som oppfylte QC-kriteriene
17. april 2019
Sist bekreftet
1. april 2019
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 201507727
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
JA
IPD-planbeskrivelse
De-identified data and guide will be made available to other investigators upon request.
IPD-delingstidsramme
Requested data will be made available upon publication of the project.
Tilgangskriterier for IPD-deling
Please contact corresponding author Dr. Paul Windschitl at paul-windschitl@uiowa.edu
IPD-deling Støtteinformasjonstype
- ANALYTIC_CODE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Radon & Smoking Synergistic
-
Wroclaw Medical UniversityFullførtArtrose | Degenerativ skivesykdom
-
University of North DakotaNational Institute of General Medical Sciences (NIGMS)FullførtLungekreftForente stater
-
University of North DakotaFullførtLungekreftForente stater
-
Temple UniversityUkjentStillesittende livsstil | Sigarett røykingForente stater
-
Forschungsinstitut für Balneologie und Kurortwissenschaft...In-patient rehabilition hospital Klinik Bad Brambach; University hospital...Fullført
-
University of California, San FranciscoFullført
-
National Cancer Institute (NCI)FullførtSarkom | EggstokkreftForente stater
-
University of ChicagoNational Cancer Institute (NCI)FullførtLeverkreft | Galleblæren kreft | Ekstrahepatisk gallekanalkreftForente stater
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)FullførtRøykeslutt | TobakksbruksforstyrrelseForente stater
-
University of HoustonUniversity of Pittsburgh; Brown University; University of OklahomaRekruttering